![]() |
|
|
Vol. 62, Issue 3, 660-671, September 2002
Departments of Cancer Biology (L.M.B., K.L.C., J.L., Y.X.) and
Gynecology and Obstetrics (Y.X.), Cleveland Clinic Foundation,
Cleveland, Ohio; and Department of Chemistry, Cleveland State
University, Cleveland, Ohio (L.M.B., Y.X.)
The signaling pathways that lysophosphatidic acid (LPA) and
sphingosine-1-phosphate (S1P) use to activate Akt in ovarian cancer cells are investigated here. We show for the first time, with the use
of both pharmacological and genetic inhibitors, that the kinase
activity and S473 phosphorylation of Akt induced by LPA and S1P
requires both mitogen-activated protein (MAP) kinase kinase (MEK) and
p38 MAP kinase, and MEK is likely to be upstream of p38, in HEY ovarian
cancer cells. The requirement for both MEK and p38 is cell type- and
stimulus-specific. Among 12 cell lines that we tested, 11 respond to
LPA and S1P and all of the responsive cell lines require p38 but only
nine of them require MEK. Among different stimuli tested,
platelet-derived growth factor stimulates S473 phosphorylation of Akt
in a MEK- and p38-dependent manner. However, epidermal growth factor,
thrombin, and endothelin-1-stimulated Akt S473 phosphorylation require
p38 but not MEK. Insulin, on the other hand, stimulates Akt S473
phosphorylation independent of both MEK and p38 in HEY cells. T308
phosphorylation stimulated by LPA/S1P requires MEK but not p38
activation. MEK and p38 activation were sufficient for Akt S473 but not
T308 phosphorylation in HEY cells. In contrast to S1P and PDGF, LPA
requires Rho for Akt S473 phosphorylation, and Rho is upstream of
phosphatidylinositol 3-kinase (PI3-K). LPA/S1P-induced Akt activation
may be involved in cell survival, because LPA and S1P treatment in HEY
ovarian cancer cells results in a decrease in paclitaxel-induced
caspase-3 activity in a PI3-K/MEK/p38-dependent manner.
This article has been cited by other articles:
![]() |
R. Wu, H. Kausar, P. Johnson, D. E. Montoya-Durango, M. Merchant, and M. J. Rane Hsp27 Regulates Akt Activation and Polymorphonuclear Leukocyte Apoptosis by Scaffolding MK2 to Akt Signal Complex J. Biol. Chem., July 27, 2007; 282(30): 21598 - 21608. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, D. Wang, Z. Zhao, Y. Xiao, S. Sengupta, Y. Xiao, R. Zhang, K. Lauber, S. Wesselborg, L. Feng, et al. Caspase-3-dependent Activation of Calcium-independent Phospholipase A2 Enhances Cell Migration in Non-apoptotic Ovarian Cancer Cells J. Biol. Chem., September 29, 2006; 281(39): 29357 - 29368. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Jin and J. S. Karliner Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKC{varepsilon} dependent mechanism Cardiovasc Res, September 1, 2006; 71(4): 725 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. French, J. J. Upson, S. N. Keller, Y. Zhuang, J. K. Yun, and C. D. Smith Antitumor Activity of Sphingosine Kinase Inhibitors J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 596 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ren, Y.-j. Xiao, L. S. Singh, X. Zhao, Z. Zhao, L. Feng, T. M. Rose, G. D. Prestwich, and Y. Xu Lysophosphatidic Acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res., March 15, 2006; 66(6): 3006 - 3014. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lee, R. F. Swaby, Y. Liang, S. Yu, S. Liu, K. H. Lu, R. C. Bast Jr., G. B. Mills, and X. Fang Lysophosphatidic Acid Is a Major Regulator of Growth-Regulated Oncogene {alpha} in Ovarian Cancer. Cancer Res., March 1, 2006; 66(5): 2740 - 2748. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Kang, Y. D. Yoon, M. H. Han, S.-B. Han, K. Lee, K. H. Lee, S.-K. Park, and H. M. Kim Glabridin Suppresses Intercellular Adhesion Molecule-1 Expression in Tumor Necrosis Factor-{alpha}-Stimulated Human Umbilical Vein Endothelial Cells by Blocking Sphingosine Kinase Pathway: Implications of Akt, Extracellular Signal-Regulated Kinase, and Nuclear Factor-{kappa}B/Rel Signaling Pathways Mol. Pharmacol., March 1, 2006; 69(3): 941 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pchejetski, M. Golzio, E. Bonhoure, C. Calvet, N. Doumerc, V. Garcia, C. Mazerolles, P. Rischmann, J. Teissie, B. Malavaud, et al. Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models Cancer Res., December 15, 2005; 65(24): 11667 - 11675. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Q. Dong and F. Liu PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E187 - E196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Goparaju, P. S. Jolly, K. R. Watterson, M. Bektas, S. Alvarez, S. Sarkar, L. Mel, I. Ishii, J. Chun, S. Milstien, et al. The S1P2 Receptor Negatively Regulates Platelet-Derived Growth Factor-Induced Motility and Proliferation Mol. Cell. Biol., May 15, 2005; 25(10): 4237 - 4249. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, N. Haney, D. Kropp, A. F. Kabore, J. B. Johnston, and S. B. Gibson Lysophosphatidic Acid (LPA) Protects Primary Chronic Lymphocytic Leukemia Cells from Apoptosis through LPA Receptor Activation of the Anti-apoptotic Protein AKT/PKB J. Biol. Chem., March 11, 2005; 280(10): 9498 - 9508. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Suomalainen, V. Pentikainen, and L. Dunkel Sphingosine-1-Phosphate Inhibits Nuclear Factor {kappa}B Activation and Germ Cell Apoptosis in the Human Testis Independently of Its Receptors Am. J. Pathol., March 1, 2005; 166(3): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Chen, J. Y. Grey, S. Thomas, F.-H. Qiu, R. M. Medford, M. A. Wasserman, and C. Kunsch Sphingosine kinase-1 mediates TNF-{alpha}-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1452 - H1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gruber, B. Kandler, C. Jindra, G. Watzak, and G. Watzek Dental Pulp Fibroblasts Contain Target Cells for Lysophosphatidic Acid J. Dent. Res., June 1, 2004; 83(6): 491 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gonzalez, G. Tripathi, E. J. Carter, L. J. Cobb, D. A. M. Salih, F. A. Lovett, C. Holding, and J. M Pell Akt2, a Novel Functional Link between p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Pathways in Myogenesis Mol. Cell. Biol., May 1, 2004; 24(9): 3607 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pervin, R. Singh, W. A. Freije, and G. Chaudhuri MKP-1-Induced Dephosphorylation of Extracellular Signal-Regulated Kinase Is Essential for Triggering Nitric Oxide-Induced Apoptosis in Human Breast Cancer Cell Lines: Implications in Breast Cancer Cancer Res., December 15, 2003; 63(24): 8853 - 8860. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hirose, M. Katayama, D. Stokoe, D. A. Haas-Kogan, M. S. Berger, and R. O. Pieper The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents Mol. Cell. Biol., November 15, 2003; 23(22): 8306 - 8315. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tan, M. Groszer, A. M. Tan, A. Pandya, X. Liu, and C.-W. Xie Phosphoinositide 3-Kinase Cascade Facilitates {micro}-Opioid Desensitization in Sensory Neurons by Altering G-Protein-Effector Interactions J. Neurosci., November 12, 2003; 23(32): 10292 - 10301. [Abstract] [Full Text] [PDF] |
||||